Clinical Edge Journal Scan

Pediatric atopic dermatitis: Food allergy common but AD rarely triggered by food


 

Key clinical point: Although food allergy (FA) is common among pediatric patients with atopic dermatitis (AD), immunoglobulin E (IgE) mediates the majority of instances and very few patients report food-triggered AD (FTAD), cautioning against unnecessary dietary restrictions.

Major finding: I gE-mediated FA was common in the overall cohort (55%) irrespective of the severity of AD (mild, 60%; moderate, 45%; severe, 57%), whereas FTAD was rare (3%) and diagnosed in only 2%, 6%, and 4% of patients with mild, moderate, and severe AD, respectively. In patients with AD only, more patients developed IgE-mediated FA vs FTAD (29% vs 5%).

Study details: Findings are from a retrospective study including 372 pediatric patients with AD, of which 29% had moderate AD and 18% had severe AD.

Disclosures: This study was funded by University of Wisconsin-Madison. The authors declared no conflicts of interest.

Source: Li JC et al. Prevalence of food allergy diagnosis in pediatric patients with atopic dermatitis referred to allergy and/or dermatology subspecialty clinics. J Allergy Clin Immunol Pract. 2022 (Jun 8). Doi: 10.1016/j.jaip.2022.05.028

Recommended Reading

Eczema causes substantial burden for many infants and preschoolers
MDedge Dermatology
Methotrexate’s impact on COVID-19 vaccination: New insights made
MDedge Dermatology
‘I shall harm’
MDedge Dermatology
Multi-dimensional and heterogeneous nature of disease burden in atopic dermatitis
MDedge Dermatology
Adolescents and children with moderate-to-severe atopic dermatitis benefit from dupilumab
MDedge Dermatology
Moderate-to-severe atopic dermatitis: Abrocitinib improves clinical scores in IGA nonresponders
MDedge Dermatology
Atopic dermatitis: Improvement in disease severity and skin barrier function with dupilumab
MDedge Dermatology
Atopic dermatitis: Upadacitinib-induced acne does not pose a significant safety risk
MDedge Dermatology
Difamilast shows promise as long-term therapeutic option for atopic dermatitis
MDedge Dermatology
Identifying factors associated with AD severity
MDedge Dermatology